PubMed Health⌕ Search

Biomedical subjects

M O Bricourt

Publications and source records attributed to M O Bricourt.

6 recordsLinked to original sources
PubMed2005

[Five years experience with non-pulsatile flow].

Mechanical circulatory assistances now belong to the therapeutic stock in case of advanced heart failure. Their mainspring lays on the substitution of the failing left and/or right ventricle function with a pump. The goal being to maintain or restore the system main functions. Their main indication is a bridge to transplant mechanical circulatory assistance, allowing the patient to await transplantation. However, indications for definitive implantation appear in case of transplantation counter indication, mechanical circulatory assistances already emerging as a possible alternative to transplantation. For over 10 years, we have used pulsatile flow assistances, either with pneumatic ventricles or electro-mechanic implantable left ventricles. We henceforth observe the development of a new generation of implantable assistance providing a non-pulsatile flow. These are axial pumps. We evaluated the first model, the DeBakey axial pump which became the most used axial pump worldwide. We now observe the development of other axial pumps as well as the development of new implantable centrifugal pumps.

Assisted Circulation↗
PubMed2004

[Pediatric mechanical circulatory assistance. Biventricular assistance for fulminant myocarditis in a 5 year old child].

The authors report the case of a 5 years old infant with cardiogenic shock due to a fulminant myocarditis. The severity of the shock which was refractory to conventional therapies necessitated to require to a cardiopulmonary bypass on emergency, followed by an external pneumatic bi-ventricular assistance. After 10 days (3 days with cardioplumonary bypass and 7 days of bi-ventricular assistance), the patient had been able to be disconnected of any mechanical circulatory supply with total recovery of the cardiac function.

Cardiopulmonary Bypass↗
PubMed1990

[CDP-choline improves the postoperative rehabilitation of patients with cerebral risk].

To evaluate the efficacy of CDP-choline to prevent from brain damages after surgery for high risk patients, 210 patients receiving pre and post operative parenteral CDP-choline were compared to 204 controls (mean age 73 years) in a multicenter open randomised study. Quality and delay of anesthetic recovery were assessed. Cognitive screening test and self-control scale (simplified Mini Mental Status test and Barthel Index) were performed the day before and the first and fourth day after surgery. CDP-choline does not enhance quality or delay of anesthetic recovery but increases the percentage of subjects with a better fourth post-operative than preoperative cognitive and self-control test (p less than 0.05).

Aged↗